Global Biopharma Plastics Market

Biopharma Plastics Comprehensive Study by Application (Syringe, Gloves and masks, Depth filter, Containers, Others), Types (Polyethylene, Polypropylene, Polyvinyl chloride, Polyethylene terephthalate, Polyolefin), End Users (Pharmaceutical and Biotechnology, Medical Device, Food and beverages, Cosmetic and personal care, Healthcare, Agriculture, Packaging, Others) Players and Region - Global Market Outlook to 2028

Biopharma Plastics Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 11.35%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Biopharma Plastics
Biopharma plastics are specialized materials specifically designed for applications in the pharmaceutical and biopharmaceutical industry. They are characterized by their high purity, biocompatibility, chemical inertness, and resistance to degradation from biological and chemical agents. These plastics are engineered to meet the specific need of the industry, ensuring the integrity, stability, sterility of pharmaceutical products. This are designed to submit with regulatory standard to ensure the safety and quality of pharmaceutical products. This growth is attributed to the increasing demand for biopharmaceuticals, stringent regulatory requirements for packaging materials, and the rising awareness about the environmental impact of traditional plastics. The biopharma industry is characterized by a high level of research and development activity, as companies invest in developing new drugs and delivery systems. This is driving demand for specialized biopharma plastics that can support this research and development, such as laboratory equipment and diagnostic devices.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
CAGR11.35%


The market has been characterized by the presence of key players along with a few medium and small regional players. Major players are continuously working on developing polymers for the production of biopharma plastics owing to the rising demand for biopharma plastic components from the healthcare industry. Analyst at AMA Research estimates that United States, Germany Players will contribute the maximum growth to Global Biopharma Plastics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Dupont (United States), Eastman Chemical Company (United States), Evonik Industries (Germany), BASF SE (Germany), Teijin Limited (Japan), Mitsubishi Chemical Corporation (Japan), Lanxess AG (Germany), West Pharmaceutical Services (United States), SABIC (South Arabia) and Covestro AG (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Plastipak Holdings (United States), Jindal Poly Films Limited (India), Catalent (United States), Gerresheimer AG (Germany) and Amcor plc (Australia).

Segmentation Overview
AMA Research has segmented the market of Global Biopharma Plastics market by , Application (Syringe, Gloves and masks, Depth filter, Containers and Others) and Region.



On the basis of geography, the market of Biopharma Plastics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Types, the sub-segment i.e. Polyethylene will boost the Biopharma Plastics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Users, the sub-segment i.e. Pharmaceutical and Biotechnology will boost the Biopharma Plastics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology advancement in biopharma plastics

Market Growth Drivers:
Growing focus of Patient safety and Product quality, Rising Healthcare Concern and Rising the assumption of personalized medicines

Challenges:
Limited availability of biopharm plastics

Restraints:
Environmental Concern and High Cost of biopharma plastics

Opportunities:
Development of biocompatible plastics for implantable medical devices and drug delivery systems.

Market Leaders and their expansionary development strategies
In October 2023, Teijin and Evonik Industries entered into a definitive agreement to merge their respective bioplastics businesses which is aiming to combine their expertise and resources to become a major force in the bio-based materials market.
In December 2023, Teijin Limited announced the development of a new bio-based polybutylene succinate (PBS) resin with improved heat resistance. This new material is expected to expand the applications of PBS in the biopharma plastics market.
The Standard for biocompatibility established by the United States Pharmacopeia (USP) and widely used in the biopharma industry. ISO 10993 is International standard for the biological evaluation of medical devices, providing a framework for assessing the safety of biopharma plastics.

Key Target Audience
Contract Research Organization, Potetial Investors, Research Firm and consultation, Hospitals and clinics and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Syringe
  • Gloves and masks
  • Depth filter
  • Containers
  • Others
By Types
  • Polyethylene
  • Polypropylene
  • Polyvinyl chloride
  • Polyethylene terephthalate
  • Polyolefin

By End Users
  • Pharmaceutical and Biotechnology
  • Medical Device
  • Food and beverages
  • Cosmetic and personal care
  • Healthcare
  • Agriculture
  • Packaging
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing focus of Patient safety and Product quality
      • 3.2.2. Rising Healthcare Concern
      • 3.2.3. Rising the assumption of personalized medicines
    • 3.3. Market Challenges
      • 3.3.1. Limited availability of biopharm plastics
    • 3.4. Market Trends
      • 3.4.1. Technology advancement in biopharma plastics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biopharma Plastics, by Application, Types, End Users and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Biopharma Plastics (Value)
      • 5.2.1. Global Biopharma Plastics by: Application (Value)
        • 5.2.1.1. Syringe
        • 5.2.1.2. Gloves and masks
        • 5.2.1.3. Depth filter
        • 5.2.1.4. Containers
        • 5.2.1.5. Others
      • 5.2.2. Global Biopharma Plastics by: Types (Value)
        • 5.2.2.1. Polyethylene
        • 5.2.2.2. Polypropylene
        • 5.2.2.3. Polyvinyl chloride
        • 5.2.2.4. Polyethylene terephthalate
        • 5.2.2.5. Polyolefin
      • 5.2.3. Global Biopharma Plastics by: End Users (Value)
        • 5.2.3.1. Pharmaceutical and Biotechnology
        • 5.2.3.2. Medical Device
        • 5.2.3.3. Food and beverages
        • 5.2.3.4. Cosmetic and personal care
        • 5.2.3.5. Healthcare
        • 5.2.3.6. Agriculture
        • 5.2.3.7. Packaging
        • 5.2.3.8. Others
      • 5.2.4. Global Biopharma Plastics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biopharma Plastics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Dupont (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Eastman Chemical Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Evonik Industries (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BASF SE (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teijin Limited (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mitsubishi Chemical Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lanxess AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. West Pharmaceutical Services (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SABIC (South Arabia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Covestro AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biopharma Plastics Sale, by Application, Types, End Users and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Biopharma Plastics (Value)
      • 7.2.1. Global Biopharma Plastics by: Application (Value)
        • 7.2.1.1. Syringe
        • 7.2.1.2. Gloves and masks
        • 7.2.1.3. Depth filter
        • 7.2.1.4. Containers
        • 7.2.1.5. Others
      • 7.2.2. Global Biopharma Plastics by: Types (Value)
        • 7.2.2.1. Polyethylene
        • 7.2.2.2. Polypropylene
        • 7.2.2.3. Polyvinyl chloride
        • 7.2.2.4. Polyethylene terephthalate
        • 7.2.2.5. Polyolefin
      • 7.2.3. Global Biopharma Plastics by: End Users (Value)
        • 7.2.3.1. Pharmaceutical and Biotechnology
        • 7.2.3.2. Medical Device
        • 7.2.3.3. Food and beverages
        • 7.2.3.4. Cosmetic and personal care
        • 7.2.3.5. Healthcare
        • 7.2.3.6. Agriculture
        • 7.2.3.7. Packaging
        • 7.2.3.8. Others
      • 7.2.4. Global Biopharma Plastics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biopharma Plastics: by Application(USD Million)
  • Table 2. Biopharma Plastics Syringe , by Region USD Million (2017-2022)
  • Table 3. Biopharma Plastics Gloves and masks , by Region USD Million (2017-2022)
  • Table 4. Biopharma Plastics Depth filter , by Region USD Million (2017-2022)
  • Table 5. Biopharma Plastics Containers , by Region USD Million (2017-2022)
  • Table 6. Biopharma Plastics Others , by Region USD Million (2017-2022)
  • Table 7. Biopharma Plastics: by Types(USD Million)
  • Table 8. Biopharma Plastics Polyethylene , by Region USD Million (2017-2022)
  • Table 9. Biopharma Plastics Polypropylene , by Region USD Million (2017-2022)
  • Table 10. Biopharma Plastics Polyvinyl chloride , by Region USD Million (2017-2022)
  • Table 11. Biopharma Plastics Polyethylene terephthalate , by Region USD Million (2017-2022)
  • Table 12. Biopharma Plastics Polyolefin , by Region USD Million (2017-2022)
  • Table 13. Biopharma Plastics: by End Users(USD Million)
  • Table 14. Biopharma Plastics Pharmaceutical and Biotechnology , by Region USD Million (2017-2022)
  • Table 15. Biopharma Plastics Medical Device , by Region USD Million (2017-2022)
  • Table 16. Biopharma Plastics Food and beverages , by Region USD Million (2017-2022)
  • Table 17. Biopharma Plastics Cosmetic and personal care , by Region USD Million (2017-2022)
  • Table 18. Biopharma Plastics Healthcare , by Region USD Million (2017-2022)
  • Table 19. Biopharma Plastics Agriculture , by Region USD Million (2017-2022)
  • Table 20. Biopharma Plastics Packaging , by Region USD Million (2017-2022)
  • Table 21. Biopharma Plastics Others , by Region USD Million (2017-2022)
  • Table 22. South America Biopharma Plastics, by Country USD Million (2017-2022)
  • Table 23. South America Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 24. South America Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 25. South America Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 26. Brazil Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 27. Brazil Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 28. Brazil Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 29. Argentina Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 30. Argentina Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 31. Argentina Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 32. Rest of South America Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 33. Rest of South America Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 34. Rest of South America Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 35. Asia Pacific Biopharma Plastics, by Country USD Million (2017-2022)
  • Table 36. Asia Pacific Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 37. Asia Pacific Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 38. Asia Pacific Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 39. China Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 40. China Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 41. China Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 42. Japan Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 43. Japan Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 44. Japan Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 45. India Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 46. India Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 47. India Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 48. South Korea Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 49. South Korea Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 50. South Korea Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 51. Taiwan Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 52. Taiwan Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 53. Taiwan Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 54. Australia Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 55. Australia Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 56. Australia Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 58. Rest of Asia-Pacific Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 60. Europe Biopharma Plastics, by Country USD Million (2017-2022)
  • Table 61. Europe Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 62. Europe Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 63. Europe Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 64. Germany Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 65. Germany Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 66. Germany Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 67. France Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 68. France Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 69. France Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 70. Italy Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 71. Italy Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 72. Italy Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 73. United Kingdom Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 74. United Kingdom Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 75. United Kingdom Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 76. Netherlands Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 77. Netherlands Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 78. Netherlands Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 79. Rest of Europe Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 80. Rest of Europe Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 81. Rest of Europe Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 82. MEA Biopharma Plastics, by Country USD Million (2017-2022)
  • Table 83. MEA Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 84. MEA Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 85. MEA Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 86. Middle East Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 87. Middle East Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 88. Middle East Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 89. Africa Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 90. Africa Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 91. Africa Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 92. North America Biopharma Plastics, by Country USD Million (2017-2022)
  • Table 93. North America Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 94. North America Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 95. North America Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 96. United States Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 97. United States Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 98. United States Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 99. Canada Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 100. Canada Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 101. Canada Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 102. Mexico Biopharma Plastics, by Application USD Million (2017-2022)
  • Table 103. Mexico Biopharma Plastics, by Types USD Million (2017-2022)
  • Table 104. Mexico Biopharma Plastics, by End Users USD Million (2017-2022)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Biopharma Plastics: by Application(USD Million)
  • Table 116. Biopharma Plastics Syringe , by Region USD Million (2023-2028)
  • Table 117. Biopharma Plastics Gloves and masks , by Region USD Million (2023-2028)
  • Table 118. Biopharma Plastics Depth filter , by Region USD Million (2023-2028)
  • Table 119. Biopharma Plastics Containers , by Region USD Million (2023-2028)
  • Table 120. Biopharma Plastics Others , by Region USD Million (2023-2028)
  • Table 121. Biopharma Plastics: by Types(USD Million)
  • Table 122. Biopharma Plastics Polyethylene , by Region USD Million (2023-2028)
  • Table 123. Biopharma Plastics Polypropylene , by Region USD Million (2023-2028)
  • Table 124. Biopharma Plastics Polyvinyl chloride , by Region USD Million (2023-2028)
  • Table 125. Biopharma Plastics Polyethylene terephthalate , by Region USD Million (2023-2028)
  • Table 126. Biopharma Plastics Polyolefin , by Region USD Million (2023-2028)
  • Table 127. Biopharma Plastics: by End Users(USD Million)
  • Table 128. Biopharma Plastics Pharmaceutical and Biotechnology , by Region USD Million (2023-2028)
  • Table 129. Biopharma Plastics Medical Device , by Region USD Million (2023-2028)
  • Table 130. Biopharma Plastics Food and beverages , by Region USD Million (2023-2028)
  • Table 131. Biopharma Plastics Cosmetic and personal care , by Region USD Million (2023-2028)
  • Table 132. Biopharma Plastics Healthcare , by Region USD Million (2023-2028)
  • Table 133. Biopharma Plastics Agriculture , by Region USD Million (2023-2028)
  • Table 134. Biopharma Plastics Packaging , by Region USD Million (2023-2028)
  • Table 135. Biopharma Plastics Others , by Region USD Million (2023-2028)
  • Table 136. South America Biopharma Plastics, by Country USD Million (2023-2028)
  • Table 137. South America Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 138. South America Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 139. South America Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 140. Brazil Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 141. Brazil Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 142. Brazil Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 143. Argentina Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 144. Argentina Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 145. Argentina Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 146. Rest of South America Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 147. Rest of South America Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 148. Rest of South America Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 149. Asia Pacific Biopharma Plastics, by Country USD Million (2023-2028)
  • Table 150. Asia Pacific Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 151. Asia Pacific Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 152. Asia Pacific Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 153. China Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 154. China Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 155. China Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 156. Japan Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 157. Japan Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 158. Japan Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 159. India Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 160. India Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 161. India Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 162. South Korea Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 163. South Korea Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 164. South Korea Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 165. Taiwan Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 166. Taiwan Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 167. Taiwan Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 168. Australia Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 169. Australia Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 170. Australia Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 171. Rest of Asia-Pacific Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 172. Rest of Asia-Pacific Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 173. Rest of Asia-Pacific Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 174. Europe Biopharma Plastics, by Country USD Million (2023-2028)
  • Table 175. Europe Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 176. Europe Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 177. Europe Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 178. Germany Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 179. Germany Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 180. Germany Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 181. France Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 182. France Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 183. France Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 184. Italy Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 185. Italy Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 186. Italy Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 187. United Kingdom Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 188. United Kingdom Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 189. United Kingdom Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 190. Netherlands Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 191. Netherlands Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 192. Netherlands Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 193. Rest of Europe Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 194. Rest of Europe Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 195. Rest of Europe Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 196. MEA Biopharma Plastics, by Country USD Million (2023-2028)
  • Table 197. MEA Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 198. MEA Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 199. MEA Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 200. Middle East Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 201. Middle East Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 202. Middle East Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 203. Africa Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 204. Africa Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 205. Africa Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 206. North America Biopharma Plastics, by Country USD Million (2023-2028)
  • Table 207. North America Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 208. North America Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 209. North America Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 210. United States Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 211. United States Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 212. United States Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 213. Canada Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 214. Canada Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 215. Canada Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 216. Mexico Biopharma Plastics, by Application USD Million (2023-2028)
  • Table 217. Mexico Biopharma Plastics, by Types USD Million (2023-2028)
  • Table 218. Mexico Biopharma Plastics, by End Users USD Million (2023-2028)
  • Table 219. Research Programs/Design for This Report
  • Table 220. Key Data Information from Secondary Sources
  • Table 221. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biopharma Plastics: by Application USD Million (2017-2022)
  • Figure 5. Global Biopharma Plastics: by Types USD Million (2017-2022)
  • Figure 6. Global Biopharma Plastics: by End Users USD Million (2017-2022)
  • Figure 7. South America Biopharma Plastics Share (%), by Country
  • Figure 8. Asia Pacific Biopharma Plastics Share (%), by Country
  • Figure 9. Europe Biopharma Plastics Share (%), by Country
  • Figure 10. MEA Biopharma Plastics Share (%), by Country
  • Figure 11. North America Biopharma Plastics Share (%), by Country
  • Figure 12. Global Biopharma Plastics share by Players 2022 (%)
  • Figure 13. Global Biopharma Plastics share by Players (Top 3) 2022(%)
  • Figure 14. Global Biopharma Plastics share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Dupont (United States) Revenue, Net Income and Gross profit
  • Figure 17. Dupont (United States) Revenue: by Geography 2022
  • Figure 18. Eastman Chemical Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Eastman Chemical Company (United States) Revenue: by Geography 2022
  • Figure 20. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Evonik Industries (Germany) Revenue: by Geography 2022
  • Figure 22. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 23. BASF SE (Germany) Revenue: by Geography 2022
  • Figure 24. Teijin Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Teijin Limited (Japan) Revenue: by Geography 2022
  • Figure 26. Mitsubishi Chemical Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Mitsubishi Chemical Corporation (Japan) Revenue: by Geography 2022
  • Figure 28. Lanxess AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Lanxess AG (Germany) Revenue: by Geography 2022
  • Figure 30. West Pharmaceutical Services (United States) Revenue, Net Income and Gross profit
  • Figure 31. West Pharmaceutical Services (United States) Revenue: by Geography 2022
  • Figure 32. SABIC (South Arabia) Revenue, Net Income and Gross profit
  • Figure 33. SABIC (South Arabia) Revenue: by Geography 2022
  • Figure 34. Covestro AG (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Covestro AG (Germany) Revenue: by Geography 2022
  • Figure 36. Global Biopharma Plastics: by Application USD Million (2023-2028)
  • Figure 37. Global Biopharma Plastics: by Types USD Million (2023-2028)
  • Figure 38. Global Biopharma Plastics: by End Users USD Million (2023-2028)
  • Figure 39. South America Biopharma Plastics Share (%), by Country
  • Figure 40. Asia Pacific Biopharma Plastics Share (%), by Country
  • Figure 41. Europe Biopharma Plastics Share (%), by Country
  • Figure 42. MEA Biopharma Plastics Share (%), by Country
  • Figure 43. North America Biopharma Plastics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Dupont (United States)
  • Eastman Chemical Company (United States)
  • Evonik Industries (Germany)
  • BASF SE (Germany)
  • Teijin Limited (Japan)
  • Mitsubishi Chemical Corporation (Japan)
  • Lanxess AG (Germany)
  • West Pharmaceutical Services (United States)
  • SABIC (South Arabia)
  • Covestro AG (Germany)
Additional players considered in the study are as follows:
Plastipak Holdings (United States) , Jindal Poly Films Limited (India) , Catalent (United States) , Gerresheimer AG (Germany) , Amcor plc (Australia)
Select User Access Type

Key Highlights of Report


Jan 2024 217 Pages 93 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biopharma Plastics Market Quantitative research analysis
Global Biopharma Plastics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Dupont (United States), Eastman Chemical Company (United States), Evonik Industries (Germany), BASF SE (Germany), Teijin Limited (Japan), Mitsubishi Chemical Corporation (Japan), Lanxess AG (Germany), West Pharmaceutical Services (United States), SABIC (South Arabia) and Covestro AG (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology advancement in biopharma plastics" is seen as one of major influencing trends for Biopharma Plastics Market during projected period 2022-2028.
The Biopharma Plastics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Biopharma Plastics Market to reach USD15950.0 Million by 2028.

Know More About Global Biopharma Plastics Market Report?

Have a Query? Click Here

Other Related Reports

PFAS Testing Comprehensive Study by Application (Food Packaging, Water Samples, Foam Products, Textiles, Others), PFAS Type (Perfluorooctanoic acid (PFOA), Perfluorooctane sulfonic acid (PFOS), Perfl...
$ 3800
Microbial Fermentation Comprehensive Study by Type (Enzymes, Organic Acids, Vitamins, Amino Acids, Others), Application (Pharmaceutical, Food & Beverages, Industrial Chemical, Agricultural, Others), ...
$ 3800